CS-Keys, an Indianapolis-based developer of cancer-specific biomarkers, has raised $6.25 million in Series A funding. Triathlon Medical Ventures led the deal, and was joined by Clarian Health Ventures, Prolog Venture, Ceres Venture Fund and Spring Mill Venture Partners.
PRESS RELEASE
CS-Keys, an Indianapolis-based company creating cancer-specific biomarkers using advanced proteomics for diagnostic and therapeutic applications, announced that it has closed on $6.25 million of Series A financing. Triathlon Medical Ventures, which seed funded the company, led the financing round. The funding marks two notable mentions: it is the first investment by the newly formed Clarian Health Ventures, and two venture capital firms with their first investments in Indiana also joined the financing
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.